hit counter

Lecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping

Editorial card showing lecanemab maintenance dosing and Alzheimer's blood biomarkers with blood vials, amyloid PET imagery, and biomarker trajectory lines.

Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment stops: a 2026 PK/PD model estimated that half of the Aβ42/40 treatment effect is lost within 0.5 years, compared with 12.1 years for amyloid PET signal.1 Research Highlights 0.5-year rebound for Aβ42/40: Bhagunde et al. estimated that half of the Aβ42/40 treatment effect …

Read more